XANTUS EMEA-LA. Xarelto® on prevention of stroke and non-central nervous system systemic embolism in patients with non-valvular atrial fibrillation in Eastern EU, Middle East, Africa (EMEA) and Latin America (LATAM): A non-interventional study
عنوان الدراسة
XANTUS EMEA-LA. Xarelto® on prevention of stroke and non-central nervous system systemic embolism in patients with non-valvular atrial fibrillation in Eastern EU, Middle East, Africa (EMEA) and Latin America (LATAM): A non-interventional study
داعم الدراسة
Bayer
دواء الدراسة
Xarelto
رقم بروتوكول الدراسة
16691
حالة الدراسة
Ongoing
موقع الدراسة
Prince Sultan Cardiac Center (Qassim), Abdul Rahman Al-Mishari Hospital (Riyadh), King Fahad Medical City (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah), King Khalid University Hospital (Riyadh), Dallah Hospital (Riyadh), Prince Sultan Cardiac Center (Riyadh)
مرحلة الدراسة
4
التعليقات والاقتراحات
لأي استفسارات أو ملاحظات حول الخدمات الحكومية، يرجى تعبئة المعلومات المطلوبة.